DK141439B - Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof. - Google Patents

Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof. Download PDF

Info

Publication number
DK141439B
DK141439B DK240577A DK240577A DK141439B DK 141439 B DK141439 B DK 141439B DK 240577 A DK240577 A DK 240577A DK 240577 A DK240577 A DK 240577A DK 141439 B DK141439 B DK 141439B
Authority
DK
Denmark
Prior art keywords
compounds
phenoxyphenyl
analysis calculated
found
acid
Prior art date
Application number
DK240577A
Other languages
Danish (da)
Other versions
DK240577A (en
DK141439C (en
Inventor
Winston Stanley Marshall
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US752800A external-priority patent/US3649679A/en
Priority claimed from US828756A external-priority patent/US3600437A/en
Priority claimed from DK436169A external-priority patent/DK145778C/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to DK240577A priority Critical patent/DK141439B/en
Publication of DK240577A publication Critical patent/DK240577A/da
Publication of DK141439B publication Critical patent/DK141439B/en
Application granted granted Critical
Publication of DK141439C publication Critical patent/DK141439C/da

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

00 FREMLÆG6ELSESSKRIFT 141439 DANMARK (61) Intel.3 c 07 c 93/u «(21) Ansøgning nr. 2405/77 (22) Indleveret den 1. Jun. I977 (23) Løbedag 14. aug. 1969 (44) Antegningen fremlagt og frømlæggeleemkriftøt offentflggjort den 17· mST · 1 98000 PUBLICATION 141439 DENMARK (61) Intel.3 c 07 c 93 / u «(21) Application No. 2405/77 (22) Filed on 1 Jun. I977 (23) Race day 14 Aug. 1969 (44) The note presented and made available to the public on 17 · mST · 1 980

DIREKTORATET FORDIRECTORATE OF

PATENT-OG VAREMÆRKEVÆSENET (30) Prioritet begæret fra denPATENT AND TRADE MARKET (30) Priority requested from it

15. aug. 1968, 7528ΟΟ, USAug 15 1968, 7528ΟΟ US

15. aug. 1968, 752801, USAug 15 1968, 752801, US

28. maj 1969, 828756, USMay 28, 1969, 828756, US

(71) ELI LILLY AND COMPANY, 307 East McCarty Street, Indianapolis, Ιπρ diana, US.(71) ELI LILLY AND COMPANY, 307 East McCarty Street, Indianapolis, Ιπρ diana, US.

(72) Opfinder: Winston Stanley Marshall, 1937 East 'Lilac Drive, Indianapolis, Indiana, US.(72) Inventor: Winston Stanley Marshall, 1937 East 'Lilac Drive, Indianapolis, Indiana, US.

(74) Fuldmægtig under sagens behandling:(74) Plenipotentiary in the proceedings:

Ingeniørfirmaet Hofman-Bang & Boutard.Hofman-Bang & Boutard Engineering Company.

(64) Analogifremgangsmåde til fremstilling af 3-phenoxypheny 1 alkylamin-forbindelser eller syreadditionssalte deraf.(64) Analogous process for the preparation of 3-phenoxyphenyl 1 alkylamine compounds or acid addition salts thereof.

Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af hidtil ukendte 3-phenoxyphenylalkylamin-forbin-delser med den i kravets indledning angivne almene formel eller farmaceutisk acceptable syreadditionssalte deraf, hvilke forbindelser har antiinf lammatorisk virkning og en mild acetylsalicylsyre-lignende analgetisk og antipyretisk virkning.The present invention relates to an analogous process for the preparation of novel 3-phenoxyphenylalkylamine compounds of the general formula or pharmaceutically acceptable acid addition salts thereof as set forth in the preamble, which compounds have antiinflammatory and mild acetylsalicylic acid-like analgesic and antipyretic action.

Mange mennesker og dyr vides at lide af forskellige rheumatiske tilstande, der medfører betændelse, opsvulmning, ømhed, nedsat mo- ; bilitet, smerte og feber. Der findes en række tilgængelige anti-inflammatoriske midler, som har vist sig at være effektive ved den symptomatiske behandling af lidelser såsom rheumatoid arthri- 2Many people and animals are known to suffer from various rheumatic conditions that cause inflammation, swelling, tenderness, reduced mo-; mobility, pain and fever. There are a number of available anti-inflammatory agents that have been shown to be effective in the symptomatic treatment of disorders such as rheumatoid arthritis.

UU3SUU3S

tis, rheumatoid, spondylitis og osteoarthritis i hoften, men disse midler har et antal uønskede bivirkninger.tis, rheumatoid, spondylitis and osteoarthritis of the hip, but these agents have a number of unwanted side effects.

Den foreliggende opfindelses formål er at tilvejebringe hidtil u-kendte forbindelser, som er nyttige i lægemidler til behandling af inflammation, smerte og feber hos mennesker og dyr. Dette opnås ved fremgangsmåden ifølge opfindelsen, som er ejendommelig ved det i kravets kendetegnende del anførte.The object of the present invention is to provide novel compounds useful in drugs for the treatment of inflammation, pain and fever in humans and animals. This is achieved by the method according to the invention, which is characterized by the characterizing part of the claim.

Ved "syreadditionssalte" skal forstås salte, der er fremstillet ved omsætning af den frie amin med en organisk eller uorganisk syre, eksempelvis hydrochlorid, hydrobromid, sulfat, bisulfat, acetat, valerat, oleat, laurat, borat, benzoat, lactat, phosphat, tosylat, citrat, maleat, fumarat, succinat, tartrat og napsylat (salt af 2-naphthalensulfonsyre).By "acid addition salts" is meant salts prepared by reaction of the free amine with an organic or inorganic acid, for example hydrochloride, hydrobromide, sulfate, bisulfate, acetate, valerate, oleate, laurate, borate, benzoate, lactate, phosphate, tosylate , citrate, maleate, fumarate, succinate, tartrate and napsylate (salt of 2-naphthalenesulfonic acid).

"alkyl med 1-5 carbonatomer" og "alkenyl med 2-6 carbonatomer" kan være såvel ligekædede som forgrenede grupper."alkyl of 1-5 carbon atoms" and "alkenyl of 2-6 carbon atoms" may be both straight and branched groups.

Alle de omhandlede forbindelser er nyttige til behandling af inflammatoriske sygdomme hos pattedyr. Ud over deres antiinflammatoriske aktivitet udøver forbindelserne en mild analgetisk og antipyretisk aktivitet. De kan anvendes i terapeutiske blandinger, der som aktiv ingrediens indeholder en eller flere af forbindelserne sammen med et farmaceutisk acceptabelt fortyndingsmiddel eller bærestof. Forbindelserne indgives i reglen til pattedyr i doser på 0,2-5,0 mg/kg legemsvægt daglig, enten i enkelte eller i opdelte doser i løbet af 24 timer. Det er underforstået, at fremstillingen af såvel den d- som 1-isomere af α-alkyl-forbindelserne er omfattet af opfindelsen. Således kan f.eks. α-alkylsyreme spaltes i deres d- og 1-isomere ved velkendte metoder, og de to isomere har vist sig at have i det væsentlige identisk virkning. Man kan således anvende såvel den racemiske blanding som den d- og 1-isomere ved behandlingen af betændelse, smerte og feber hos pattedyr.All of the compounds of the present invention are useful for the treatment of inflammatory diseases in mammals. In addition to their anti-inflammatory activity, the compounds exert a mild analgesic and antipyretic activity. They can be used in therapeutic mixtures containing as active ingredient one or more of the compounds together with a pharmaceutically acceptable diluent or carrier. The compounds are usually administered to mammals at doses of 0.2-5.0 mg / kg body weight daily, either in single or divided doses over 24 hours. It is to be understood that the preparation of both the d- and 1-isomers of the α-alkyl compounds is encompassed by the invention. Thus, e.g. The α-alkyl acids are cleaved into their d and 1 isomers by well known methods and the two isomers have been found to have essentially identical effect. Thus, both the racemic mixture and the d- and 1-isomer can be used in the treatment of inflammation, pain and fever in mammals.

Nogle af de ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser har overraskende vist sig at forhøje den analgetiske virkning af et antal analgetiske midler. Forhøjelsen af den anal- 3 UU39 getiske virkning forekommer, når ca. 1 vægtdel af forbindelsen, der er fremstillet ved fremgangsmåden ifølge opfindelsen , indgives i det væsentlige samtidig med eller fra 1 time før til 1 time efter indgivelsen af 0,005-20 vægtdele af det analgetiske middel. Generelt kan man sige, at man for at opnå en større analgetisk virkning må indgive 0,5-50 mg/kg af en forbindelse, der er fremstillet ved fremgangsmåden ifølge opfindelsen, sammen med den sædvanlige terapeutiske dosis af det analgetiske middel.Surprisingly, some of the compounds prepared by the process of the invention have been found to increase the analgesic effect of a number of analgesic agents. The increase in the analgesic effect occurs when ca. 1 part by weight of the compound prepared by the method of the invention is administered substantially simultaneously with or from 1 hour before to 1 hour after the administration of 0.005-20 parts by weight of the analgesic agent. In general, it can be said that to obtain a greater analgesic effect, 0.5-50 mg / kg of a compound prepared by the method according to the invention must be administered together with the usual therapeutic dose of the analgesic agent.

De omhandlede forbindelser og udgangsmaterialerne for disse kan fremstilles ved velkendte reaktioner. Fremstillingen af udgangsforbindelserne er specifikt beskrevet i dansk patentansøgning nr. 4361/69. Man kan gå forskellige veje ved fremstillingen af de omhandlede forbindelser, men en række af de foretrukne reaktions- 12 Ί typer er beskrevet nedenfor. I det følgende har R , R og R^ den samme betydning som i kravets indledning, og "Ar" betegner den i den almene formel angivne gruppe: /Λ- //......Λ /“ 1The present compounds and their starting materials can be prepared by well known reactions. The preparation of the starting compounds is specifically described in Danish Patent Application No. 4361/69. Various routes may be used in the preparation of the compounds of this invention, but a number of the preferred reaction types are described below. In the following, R, R and R ^ have the same meaning as in the preamble of claim, and "Ar" denotes the group specified in the general formula: / Λ- //......Λ / “1

Ar-CILj NBSj Ar-CHg-Br NaCffj Ar-CH2-Cii HgO Ar-CH2-CC0HAr-CILj NBSj Ar-CHg-Br NaCffj Ar-CH2-Cii HgO Ar-CH2-CCOH

Methylgruppen i en passende m-methyldiarylether halogeneres ved omsætning med N-bromsuccinimid. (NBS), N-chlor-succinimid, sulfurylchlorid eller et lignende halogeneringsmiddel, ved anvendelse af en passende katalysator, såsom benzoylperoxid eller azo-bis-isobutyronitril i et inert opløsningsmiddel såsom carbontetrachlorid eller et andet halogeneret carbonhydrid. Den resulterende halogenmethyldiarylether omsættes med natrium- eller kaliumcyanid, fortrinsvis i en dimethyl-sulfoxidopløsning. Det således opnåede nitril hydrogeneres. katalytisk til den primære amin eller hydrolyseres til den tilsvarende carboxylsyre ved behandling med enten sure eller basiske reagenser på kendt måde, og syren omdannes til et amid, som reduceres til den tilsvarende amin.The methyl group in a suitable m-methyl diaryl ether is halogenated by reaction with N-bromosuccinimide. (NBS), N-chloro-succinimide, sulfuryl chloride or a similar halogenating agent, using a suitable catalyst such as benzoyl peroxide or azo-bis-isobutyronitrile in an inert solvent such as carbon tetrachloride or another halogenated hydrocarbon. The resulting halomethyl diaryl ether is reacted with sodium or potassium cyanide, preferably in a dimethyl sulfoxide solution. The nitrile thus obtained is hydrogenated. catalytic to the primary amine or hydrolyzed to the corresponding carboxylic acid by treatment with either acidic or basic reagents in known manner and the acid is converted to an amide which is reduced to the corresponding amine.

141439 4141439 4

lla. Ar-CHp-CN NaNH2/NH3 Ar-CH-CN %0 Ar-CH-COOHlla. Ar-CHp-CN NaNH2 / NH3 Ar-CH-CN% O Ar-CH-COOH

RlX2 ' R1 * H1RlX2 'R1 * H1

llb. Ar-CHp-COOH NaNH2/NH3 Ar-CH-COOHIIb. Ar-CHp-COOH NaNH2 / NH3 Ar-CH-COOH

“ kiX2 1 Bl 5 141439 a o o a V ^“KiX2 1 Bl 5 141439 a o o a V ^

O I iOO I iO

o a a 0 o- o 1 ro i a a u o-o < & a .o a a 0 o- o 1 ro i a a u o-o <& a.

< · o o · t . <? JO i? 3vi · S- S a a « o ϋ ^ o<· O o · t. <? JO i? 3vi · S- S a a «o ϋ ^ o

a 4* 8. t£Va 4 * 8. t £ V

0 o a a° M o? o- o 1 , a jn s? “· “ (Λ S - 6 -λ a a i rs o- o o= o S i i \ £ *5 • 33 /K ^ ? § sf a o=o λ ' o o a jf • a w0 o a a ° M o? o- o 1, a jn s? “·“ (Λ S - 6 -λ a a i rs o- o o = o S i i \ £ * 5 • 33 / K ^? § sf a o = o λ 'o o a jf • a w

V= ° irP . oWV = ° irP. oW

5 V H5 V H

t fi-S . ? Η I 0= o O % «t fi-S. ? Η I 0 = o O% «

O < UO <U

*a Is .* a Is.

col ' ^ & ^ a a ft o 0 o 'o 1 a wcol '^ & ^ a a ft o 0 o' o 1 a w

o= O JOo = O YES

1 ►*·« . . u o a < I o ^ g. S 8 6 L l & ** o a φ f*1 ► * · «. . u o a <I o ^ g. S 8 6 L l & ** o a φ f *

O Λ -5f HO Λ -5f H

o a a o a a . o å å Ί a° a° ^ V 7 o o= O O— oo a a o a a. o to Ί a ° a ° ^ V 7 o o = O O— o

t I It I I

£ 5 .$ H · H & > 6 141439£ 5. $ H · H &> 6 141439

Den ifølge ovennævnte reaktionsskema I fremstillede nitril kan al-kyleres med et alifatisk halogenid eller tosylat (R-jX^) i flydende ammoniak i nærvær af natriumamid under dannelse af et a-alifatisk substitueret nitril. Den alkylerede nitril hydrolyseres katalytisk til den primære amin eller hydrolyseres under dannelse af den tilsvarende carboxylsyre (reaktionsskema Ila). På lignende måde kan man alkylere en aryleddikesyre i α-stillingen i forhold til carboxylgruppen som vist i reaktionsskema Ilb.The nitrile prepared according to the above Scheme I can be alkylated with an aliphatic halide or tosylate (R-xX) in liquid ammonia in the presence of sodium amide to form an α-aliphatic substituted nitrile. The alkylated nitrile is catalytically hydrolyzed to the primary amine or hydrolyzed to give the corresponding carboxylic acid (Scheme IIa). Similarly, one can alkylate an arylic acetic acid at the α position relative to the carboxyl group as shown in Scheme IIb.

En nitril, der er fremstillet ifølge reaktionsskema I, kan om ønsket methyleres på følgende måde (reaktionsskema III): Nitrilen kondenseres med ethylformiat i basisk miljø, f.eks. i nærvær af na-triumhydrid elln· natriummethoxid i et inert carbonhydridopløs-ningsmiddel, såsom benzen. Det resulterende hydroxymethylenderivat benzoyleres ved indvirkning af enten benzoesyreanhydrid eller benzoylchlorid og pyri din; og benzoesyreesteren hydrogeneres derpå i nærvær af en ædelmetalkatalysator under dannelse af den ønskede oc-methylarylacetonitril, som derpå hydrogeneres eller hydrolyseres som ovenfor.A nitrile prepared according to Scheme I can, if desired, be methylated as follows (Scheme III): The nitrile is condensed with ethyl formate in a basic environment, e.g. in the presence of sodium hydride or sodium methoxide in an inert hydrocarbon solvent such as benzene. The resulting hydroxymethylene derivative is benzoylated by the action of either benzoic anhydride or benzoyl chloride and pyridine; and the benzoic acid ester is then hydrogenated in the presence of a noble metal catalyst to give the desired o-methylarylacetonitrile, which is then hydrogenated or hydrolyzed as above.

Eventuelt kan den ønskede oc-methylarylacetonitril fremstilles ved følgende reaktioner (reaktionsskema IV): Aryloxyacetophenon (fremstillet ved en Ullman-ethersyntese) reduceres enten med hydrogen i nærvær af en ædelmetalkatalysator eller med et metalhydrid, såsom lithiumaluminiumhydrid, lithium- eller natriumborhydrid, til den tilsvarende carbinol. Omdannelse af denne carbinol til det tilsvarende bromid kan udføres ved behandling af carbinolen med phos-phortribromid, fortrinsvis i et inert opløsningsmiddel, såsom chloroform, benzen og carbontetrachlorid. Det således opnåede bromid omsættes med natriumcyanid, fortrinsvis i dimethylsulfoxidopløs-ning under dannelse af en nitril, som derpå hydrogeneres eller hy- ' drolyseres som ovenfor.Optionally, the desired o-methylarylacetonitrile may be prepared by the following reactions (Scheme IV): carbinol. Conversion of this carbinol to the corresponding bromide can be accomplished by treating the carbinol with phosphorus tribromide, preferably in an inert solvent such as chloroform, benzene and carbon tetrachloride. The bromide thus obtained is reacted with sodium cyanide, preferably in dimethyl sulfoxide solution to form a nitrile, which is then hydrogenated or hydrolyzed as above.

En alternativ metode til fremstilling af oc-alkyl-(phenoxyphenyl)-eddikesyre-forbindelser omfatter anvendelse af Arndt-Eistert reaktionen som vist i reaktionsskema V, under anvendelse af en passende m-phenoxybenzoesyre som udgangsmateriale.An alternative method for preparing o-alkyl (phenoxyphenyl) acetic acid compounds comprises using the Arndt-Eistert reaction as shown in Scheme V, using an appropriate m-phenoxybenzoic acid as starting material.

De således opnåede α-alkylsyrer kan adskilles i deres d- og 1-iso-The α-alkyl acids thus obtained can be separated into their d- and 1-iso-

UU3SUU3S

mere på kendt måde. 2 VI. Ar-CH-fCHo XR; >. Ar-CH-(CILj._-C^ „2more in known manner. 2 VI. Ar-CH-fCHo XR; >. Ar-CH- (CILj ._- C

h ^ n \ --7 t ^ n \ v·Kh ^ n \ --7 t ^ n \ v · K

λ XC1 R1 XN^ , R -^r3 π 2 3 hvori R , R , r og n har de i kravets indledning anførte betydninger.λ XC1 R1 XN ^, R - ^ r3 π 2 3 wherein R, R, r and n have the meanings set forth in the preamble of the claim.

Udgangsmaterialerne kan fremstilles ved omsætning af det ovennævnte syrechlorid med en amin. Reaktionen udføres sædvanligvis i et inert opløsningsmiddel, såsom chloroform, benzen eller carbontetrachlorid i nærvær af et syrebindende middel, såsom pyridin, K^CO^ eller lignende, eller i et opløsningsmiddel af en tertiær amin, såsom eol-lidin, lutidin eller triethylamin.The starting materials can be prepared by reacting the above acid chloride with an amine. The reaction is usually carried out in an inert solvent such as chloroform, benzene or carbon tetrachloride in the presence of an acid binding agent such as pyridine, K 2 CO 2 or the like, or in a solvent of a tertiary amine such as eol-lidine, lutidine or triethylamine.

Fremgangsmåden ifølge opfindelsen kan belyses ved de følgende reaktionsskemaer:The process according to the invention can be illustrated by the following reaction schemes:

Vila. Ar-CH-(CHP)-Cf*° /R2 R1 ^R3Vila. Ar-CH- (CHP) -Cf * ° / R2 R1 ^ R3

LiAlH,, 5 * 4 .R2LiAlH ,, 5 * 4 .R2

Ar-CH-(CHp) -CH5-N^ R1 ;Ar-CH- (CHp) -CH5-N ^ R1;

Vllb. Ar-CH-(CH2)n-CN Hg/RaNi Ar-CH-(CH2)n-CH2-NH2 R1 * R1 1 2 3 hvori R , R , R og n har de i kravets indledning anførte betydninger.VIIb. Ar-CH- (CH2) n-CN Hg / RaNi Ar-CH- (CH2) n-CH2-NH2 R1 * R1 1 2 3 wherein R, R, R and n have the meanings set forth in the preamble of the claim.

De ønskede 3-phenoxyphenylalkylamin-forbindelser kan ved fremgangsmåden ifølge opfindelsen fremstilles f.eks. ved reduktion af et amid med et metalhydrid, såsom lithiumaluminiumhydrid (Vila). I tilfælde, hvor man ønsker at fremstille en primær amin, kan dette bekvemt ske ved hydrogenering af det tilsvarende nitril i nærvær af ammoniak og en katalysator, såsom Raney-nifckel (Vllb).The desired 3-phenoxyphenylalkylamine compounds can be prepared by the process of the invention e.g. by reducing an amide with a metal hydride such as lithium aluminum hydride (Vila). In cases where a primary amine is desired to be prepared, this can conveniently be accomplished by hydrogenation of the corresponding nitrile in the presence of ammonia and a catalyst such as Raney Nifckel (Vllb).

Fremgangsmåden ifølge opfindelsen belyses nærmere ved de følgende udførelseseksempler, hvor eksempel 1-3 og 5-7 viser fremstillingen af udgangsforbindelserne.The process according to the invention is further illustrated by the following embodiments, in which Examples 1-3 and 5-7 show the preparation of the starting compounds.

EKSEMPEL 1 8 UU 39EXAMPLE 1 8 HOURS 39

Fremstilling af 2-(3-bhenoxyphenyl)propionsyre A. 3-phenoxyacetophenon. En blanding af 908 g (6,68 mol) m-hydroxy-acetophenon, 4500 g (28,6 mol) brombenzen, 996 g (7,2 mol) vandfri kaliumcarbonat og 300 g kobberbronze opvarmedes under tilbagesvaling indtil vanddannelsen var fuldstændig, under anvendelse af en Dean-Stark vandudskiller. Blandingen omrørtes og opvarmedes under tilbagesvaling i 24 timer. Efter afkøling til stuetemperatur fortyndedes reaktionsblandingen med et lige så stort rumfang chloroform og filtreredes. Filtratet udvaskedes med 5% saltsyre, derpå med 5 % natriumhydroxid, med vand, tørredes over natriumsulfat og inddampedes i vakuum. Den olieagtige remanens destilleredes gennem en 15 cm Vigreux-kolonne, hvorved der blev opnået 918 g 3-pheno-xyacetophenon, k.p. 120-121°C (0,09 mmHg), n|p = 1,5868.Preparation of 2- (3-bhenoxyphenyl) propionic acid A. 3-phenoxyacetophenone. A mixture of 908 g (6.68 mole) of m-hydroxy-acetophenone, 4500 g (28.6 mole) of bromobenzene, 996 g (7.2 mole) of anhydrous potassium carbonate and 300 g of copper bronze was heated at reflux until the formation of water was complete, below use of a Dean-Stark water separator. The mixture was stirred and heated under reflux for 24 hours. After cooling to room temperature, the reaction mixture was diluted with an equal volume of chloroform and filtered. The filtrate was washed with 5% hydrochloric acid, then with 5% sodium hydroxide, with water, dried over sodium sulfate and evaporated in vacuo. The oily residue was distilled through a 15 cm Vigreux column to give 918 g of 3-pheno-xyacetophenone, m.p. 120-121 ° C (0.09 mmHg), n | p = 1.5868.

Analyse beregnet for C 79,22; H 5,70Analysis calculated for C, 79.22; H, 5.70

Fundet: C 79,39; H 5,79.Found: C, 79.39; H, 5.79.

B. a- methyl-3-phenoxybenzylalkoholB. α-methyl-3-phenoxybenzyl alcohol

En omrørt opløsning af 700 g m-phenoxyacetophenon i 3000 ml vandfri methanol afkøledes til 0°C på et is-acetone-bad. Der tilsattes 136 g (3,6 mol) natriumborhydrid i små portioner til opløsningen méd en sådan hastighed, at temperaturen ikke steg over 10°C. Efter at borhydridtilsætningen var til ende, henstod reaktionsblandingen til opvarmning til stuetemperatur og omrørtes i 18 timer. Herpå opvarmedes den under tilbagesvaling og omrøring i 8 timer. Der afdestilleredes ca. 400 ml methanol, og den tilbageværende opløsning inddampedes til ca. en trediedel af det oprindelige volumen i vakuum og udhældtes i isvand. Denne blanding ekstraheredes to gange med ether, gjordes sur med 6N saltsyre og ekstraheredes endnu en gang med ether. Etherekstrakterne blandedes, udvaskedes med mættet NaCl-opløsning, tørredes over vandfri natriumsulfat og inddampedes i vakuum. Den olieagtige remanens destilleredes gennem en 15 cm Vigreux-kolonne, hvorved der blev opnået 666 g a-methyl-3-phenoxybenzylalkohol, k.p. 132-134°C. (0,35 mmHg) n^ = 1,5809.A stirred solution of 700 g of m-phenoxyacetophenone in 3000 ml of anhydrous methanol was cooled to 0 ° C on an ice-acetone bath. 136 g (3.6 mole) of sodium borohydride was added in small portions to the solution at such a rate that the temperature did not rise above 10 ° C. After the borohydride addition was complete, the reaction mixture was allowed to warm to room temperature and stirred for 18 hours. Then it was heated under reflux and stirring for 8 hours. There were distilled approx. 400 ml of methanol and the remaining solution evaporated to ca. one third of the original volume in vacuo and poured into ice water. This mixture was extracted twice with ether, acidified with 6N hydrochloric acid and extracted again with ether. The ether extracts were mixed, washed with saturated NaCl solution, dried over anhydrous sodium sulfate and evaporated in vacuo. The oily residue was distilled through a 15 cm Vigreux column to give 666 g of α-methyl-3-phenoxybenzyl alcohol, b.p. 132-134 ° C. (0.35 mmHg) n + = 1.5809.

9 1414399 141439

Analyse beregnet for C 78,48; Η 6,59Analysis calculated for C, 78.48; Η 6.59

Pundet; C 78,75; Η 6,31.The pound; C, 78.75; Η 6.31.

C. oc-methvl-5-phenoxybenzylbromidC. oc-methyl-5-phenoxybenzyl bromide

En omrørt opløsning af 1357 g a-methyl-3-phenoxybenzylalkohol 1 5000 ml vandfrit CCl^ (fortørret over en molekylsi) afkøledes til 0°C. Hertil sattes 1760 g PBr^, og omrøringen og afkølingen vedligeholdtes, således at temperaturen forblev på 0-5°C under tilsætningen. Reaktionsblandingen henstod derpå til opvarmning til stuetemperatur og omrørtes natten over (ca. 12 timer). Reak-tionsblandingen hældtes derpå ud i isvand, og den organiske fase skiltes fra. Den vandige fase ekstraheredes med CCl^ og de kombinerede ekstrakter udvaskedes 3 gange med vand, tørredes over vandfrit natriumsulfat og inddampedes til tørhed i vakuum, hvorved der blev opnået 1702 g a-methyl-3-phenoxybenzylbromid som en tung, viskos olie, njp= 1,5993;A stirred solution of 1357 g of α-methyl-3-phenoxybenzyl alcohol in 5000 ml of anhydrous CCI (dried over a molecular sieve) was cooled to 0 ° C. To this was added 1760 g of PBr 2 and the stirring and cooling maintained so that the temperature remained at 0-5 ° C during the addition. The reaction mixture was then allowed to warm to room temperature and stirred overnight (about 12 hours). The reaction mixture was then poured into ice water and the organic phase separated. The aqueous phase was extracted with CCl 2 and the combined extracts were washed 3 times with water, dried over anhydrous sodium sulfate and evaporated to dryness in vacuo to give 1702 g of α-methyl-3-phenoxybenzyl bromide as a heavy viscous oil, njp 1.5993;

Analyse beregnet for C^^H^^BrO; C 60,44; H 4,71; Br 28,73;Analysis calculated for C C HH ^^ BrOO BrO; C, 60.44; H, 4.71; Br, 28.73;

Fundet; C 60,62; H 4,89; Br 28,47- D. 2-(3-,phenoxyphenyl)propionltrllfound; C, 60.62; H, 4.89; Br 28.47- D. 2- (3-, phenoxyphenyl) propionyltrl

En kraftigt omrørt suspension af 316 g 989é natriumcyanid i 5000 ml vandfrit dimethylsulfoxid (fortørret over en molekylsi) opvarmedes til 50-60°C og holdtes ved denne temperatur, mens man langsomt tilsatte 1702 g α-methyl-3-phenoxybenzylbromid. Efter at bro-midtilsætningen var til ende, hævedes temperaturen til 75°C, og blandingen omrørtes ved denne temperatur i 1,5 timer. Blandingen henstod til afkøling til stuetemperatur og omrørtes natten over ved stuetemperatur, hvorpå den hældtes ud i isvand. Den resulterende vandige suspension ekstraheredes 2 gange med ethylacetat og derpå med ether. Den organiske ekstrakt udvaskedes 2 gange med en natriumchloridopløsning, 1 gang med vand, og tørredes derpå over vandfrit natriumsulfat. Afdampningen af opløsningsmidlet i vakuum efterlod en olieagtig remanens, som destilleredes gennem en 15 cm Vigreux-kolonne, hvorved der blev opnået 1136 g 2-(3-phenoxyphenyl)v propionitril, k.p. l4l-l48°C (0,1 mmHg), njp = 1,5678.A vigorously stirred suspension of 316 g of 989 e sodium cyanide in 5000 ml of anhydrous dimethyl sulfoxide (dried over a molecular sieve) was heated to 50-60 ° C and maintained at this temperature while slowly adding 1702 g of α-methyl-3-phenoxybenzyl bromide. After the bromide addition was complete, the temperature was raised to 75 ° C and the mixture was stirred at this temperature for 1.5 hours. The mixture was allowed to cool to room temperature and stirred overnight at room temperature, then poured into ice water. The resulting aqueous suspension was extracted twice with ethyl acetate and then with ether. The organic extract was washed twice with a sodium chloride solution, once with water, and then dried over anhydrous sodium sulfate. Evaporation of the solvent in vacuo left an oily residue which was distilled through a 15 cm Vigreux column to obtain 1136 g of 2- (3-phenoxyphenyl) v propionitrile, b.p. 14-1-148 ° C (0.1 mmHg), njp = 1.5678.

Analyse beregnet for C^cH-^NO; C 80,69; H 5,87; N 6,27Analysis calculated for C ^ cH- ^NO; C, 80.69; H, 5.87; N, 6.27

Fundet; C 80,89; H 6,10; N 6,14.found; C, 80.89; H, 6.10; N, 6.14.

14U39 10 EKSEMPEL_2_ 2-(3-uhenoxyphenyl )-propionamidEXAMPLE 2 2- (3-Uhenoxyphenyl) propionamide

En opløsning af 0,5 M 2-(3-phenoxyphenyl)propionylchlorid i 300 ml tør ethylether sattes dråbevis til 2 liter flydende ammoniak under omrøring. Efter at tilsætningen var til ende, omrørtes reaktionsblandingen i 1 time, og der tilsattes 500 ml diethylether. Reaktionsblandingen blev omrørt natten over, hvorved overskud af ammoniak afdampede. Der tilsattes fortyndet saltsyre til reaktionsblandingen, etherlaget skiltes fra, udvaskedes med natriumhydroxid og vand, og tørredes over natriumsulfat. Afdampning af etheren i vakuum efterlod en gummiagtig remanens, som krystalliserede efter udrivning med koldt hexan·. Omkrystallisation fra ethylacetat og hexan gav 76,2 g 2-(3-phenoxyphenyl)propionamid, smp. 67-69°C.A solution of 0.5 M 2- (3-phenoxyphenyl) propionyl chloride in 300 ml of dry ethyl ether was added dropwise to 2 liters of liquid ammonia with stirring. After the addition was complete, the reaction mixture was stirred for 1 hour and 500 ml of diethyl ether was added. The reaction mixture was stirred overnight, thereby evaporating excess ammonia. Dilute hydrochloric acid was added to the reaction mixture, the ether layer was separated, washed with sodium hydroxide and water and dried over sodium sulfate. Evaporation of the ether in vacuo left a gummy residue which crystallized after tearing off with cold hexane ·. Recrystallization from ethyl acetate and hexane gave 76.2 g of 2- (3-phenoxyphenyl) propionamide, m.p. 67-69 ° C.

Analyse beregnet for C-^H-^NOg: C 74,66; H 6,27; N 5,81;Analysis calculated for C- HH- ^NO: C, 74.66; H, 6.27; N, 5.81;

Fundet: C 74,01; H 6,30; N 6,15.Found: C, 74.01; H, 6.30; N, 6.15.

EKSEMPEL_J_ N,N-dimethyl-2-(3-phenoxyphenyl)pronionamidExample N, N, N-dimethyl-2- (3-phenoxyphenyl) pronionamide

Til 400 ml tørt chloroform sattes 72,6 g 2-(3-phenoxyphenyl)pro-pionsyre og 36,9 g thionylchlorid. Reaktionsblandingen blev opvarmet under tilbagesvaling og omrøring i ca. 3 timer. Chloroformen afdampedes herpå, og remanensen Tanderkastedes 2 gange en azeotrop destillation med benzen. Remanensen opløstes i ethylether og sattes under omrøring og afkøling til en opløsning af 45 g dimethylamin i ethylether. Temperaturen holdtes ved ca. 0°C eller lavere under tilsætningen. Reaktionsblandingen fik lov at opvarmes til stuetemperatur og blev forsigtigt under tilbagesvaling i 1,5 timer hældt ud i isvand og gjort sur,.og ethyletherlaget blev skilt fra. Det vandige lag ekstraheredes med ethylether. Etherekstrakterne kombineredes, udvaskedes med vand, tørredes over natriumsulfat og inddampedes til et hvidt fast stof. Det faste stof opløstes i kogende hexan og henstod til langsom afkøling til stuetemperatur, hvorved der blev opnået 67,6 g N,N-dimethyl-2-(3-phenoxyphenyl)propionamid, smp. 73,5-76°C.To 400 ml of dry chloroform were added 72.6 g of 2- (3-phenoxyphenyl) propionic acid and 36.9 g of thionyl chloride. The reaction mixture was heated under reflux and stirring for ca. 3 hours. The chloroform was then evaporated and the residue Tooth was cast twice an azeotropic distillation with benzene. The residue was dissolved in ethyl ether and added with stirring and cooling to a solution of 45 g of dimethylamine in ethyl ether. The temperature was kept at approx. 0 ° C or lower during the addition. The reaction mixture was allowed to warm to room temperature and was gently refluxed for 1.5 hours in ice water and acidified, and the ethyl ether layer was separated. The aqueous layer was extracted with ethyl ether. The ether extracts were combined, washed with water, dried over sodium sulfate and evaporated to a white solid. The solid was dissolved in boiling hexane and allowed to cool to room temperature to give 67.6 g of N, N-dimethyl-2- (3-phenoxyphenyl) propionamide, m.p. 73.5 to 76 ° C.

u 141439u 141439

Analyse beregnet for c 75,80; H 7,11; N 5,20;Analysis calculated for c 75.80; H, 7.11; N, 5.20;

Pundet: C 75,93; H 6,90; N 5,27.Pound: C, 75.93; H, 6.90; N, 5.27.

EKSEMPEL_4 N, N-dime thyl- 2- (3-phenoxyphenvl) proplonam.ln -hydrochloridEXAMPLE 4 N, N-Dimethyl-2- (3-phenoxyphenyl) proplonamine hydrochloride

Til en flammetørret kolbe sattes under nitrogenatmosfære 6,08 g lithiumaluminiumhydrid og 500 ml ethylether. Blandingen omrørtes ved stuetemperatur i ca. 30 min. Til denne blanding sattes langsomt 67,3 g N,N-dimethyl-2-(3-phenoxyphenyl)propionamid (fremstillet efter fremgangsmåden i eksempel 3) opløst i 800 ml ethylether. Reaktionsblandingen opvarmedes under tilbagesvaling og omrøring natten over. Til reaktionsblandingen sattes herpå 4,65 ml vand, 3,5 ml 20% natriumhydroxid og 16,5 ml vand. Reaktionsblandingen hældtes derpå ud over is, der tilsattes yder-derligere natriumhydroxid, og reaktionsblandingen ekstraheredes med ethylether. Etherlaget udvaskedes med vand og ekstraheredes med fortyndet saltsyre. Syre ekstrakten blev udvasket med ethylether, gjort basisk med natriumhydroxid og ekstraheret to gange med ethylether. Etherekstrakterne udvaskedes med vand, tørredes over natriumsulfat og inddampedes til en olie. Olien destilleredes, hvorved der blev opnået 39,2 g N, N-dime thyl-2-(3-phenoxyphenyl)propyl-amin, k.p. 114-120°C, 0,1 mmHg, molekylvægt 255.To a flame-dried flask was added under nitrogen atmosphere 6.08 g of lithium aluminum hydride and 500 ml of ethyl ether. The mixture was stirred at room temperature for approx. 30 min. To this mixture was slowly added 67.3 g of N, N-dimethyl-2- (3-phenoxyphenyl) propionamide (prepared according to the procedure of Example 3) dissolved in 800 ml of ethyl ether. The reaction mixture was heated under reflux and stirring overnight. To the reaction mixture was then added 4.65 ml of water, 3.5 ml of 20% sodium hydroxide and 16.5 ml of water. The reaction mixture was then poured over ice, additional sodium hydroxide was added and the reaction mixture was extracted with ethyl ether. The ether layer was washed with water and extracted with dilute hydrochloric acid. The acid extract was washed with ethyl ether, made basic with sodium hydroxide and extracted twice with ethyl ether. The ether extracts were washed with water, dried over sodium sulfate and evaporated to an oil. The oil was distilled to give 39.2 g of N, N-dime thyl-2- (3-phenoxyphenyl) propylamine, m.p. 114-120 ° C, 0.1 mmHg, molecular weight 255.

Analyse beregnet for Ο^γΕ^,χΝΟ: C 79,96; H 8,29; N 5,49Analysis calculated for ΟΟ γΕΕ, χΝΟ: C 79.96; H, 8.29; N, 5.49

Pundet: C 79,76; H 8,06; N 5,38.Pound: C 79.76; H, 8.06; N, 5.38.

34 g af den ovennævnte amin opløstes i ca. 800 ml tør ethylether, og der ledtes gasformig hydrogenchlorid gennem opløsningen, indtil den var mættet. Det resulterende hvide faste bundfald filtreredes fra, udvaskedes med ethylether, tørredes delvist og omkrystalliseredes fra ethylalkohol, hvorved der blev opnået 34,3 g N,N-dimethyl-2-(3-phenoxyphenyl)propylamin-hydrcchlorid, smp. 215-217°C.34 g of the above amine was dissolved in ca. 800 ml of dry ethyl ether and gaseous hydrogen chloride were passed through the solution until saturated. The resulting white solid precipitate was filtered off, washed with ethyl ether, partially dried and recrystallized from ethyl alcohol to give 34.3 g of N, N-dimethyl-2- (3-phenoxyphenyl) propylamine hydrochloride, m.p. 215-217 ° C.

Analyse beregnet for C-^yH^NO.HCl: C 69,96; H 7,60; N 4,80Analysis calculated for C- yHH NONO.HCl: C, 69.96; H, 7.60; N, 4.80

Fundet: C 69,68; H 7,40; N 4,90.Found: C, 69.68; H, 7.40; N, 4.90.

12 U1439 EKSEMPEL_5 N-cyclopropylmethyl-2-(3-phenoxyphenyl )propionamidEXAMPLE 5 N-cyclopropylmethyl-2- (3-phenoxyphenyl) propionamide

Til 350 ml chloroform sattes 60,5 g 2-(3-phenoxyphenyl)propionsyre og 30,4 g thionylchlorid. Reaktionsblandingen opvarmedes under tilbagesvaling natten over, inddampedes, og remanensen underkastedes tre gange en azeotropisk destillation med benzen. Det dannede olie-agtige syrechlorid behandledes med chloroform. 40 g aminomethylcy-clopropan, hydrochlorid blev opløst i en ringe mængde vand, gjort basisk med 5N natriumhydroxid og ekstraheret med chloroform.To 350 ml of chloroform were added 60.5 g of 2- (3-phenoxyphenyl) propionic acid and 30.4 g of thionyl chloride. The reaction mixture was heated under reflux overnight, evaporated and the residue was subjected to azeotropic distillation with benzene three times. The resulting oily acid chloride was treated with chloroform. 40 g of aminomethylcyclopropane hydrochloride was dissolved in a small amount of water, basified with 5N sodium hydroxide and extracted with chloroform.

Det vandige lag mættedes med natriumchlorid og ekstraheredes atter med chloroform. Chloroformekstrakterne kombineredes og tørredes over natriumcarbonat og natriumsulfat. Ekstrakterne filtreredes, og der tilsattes 50 ml triethylamin. Blandingen afkøledes på et is-acetonebad. Hertil sattes dråbevis opløsningen af syrechlorid i chloroform. Der afkøledes og omrørtes under hele tilsætningen. Reaktionsblandingen henstod til opvarmning til stuetemperatur, omrørtes i 30 minutter, opvarmedes til tilbagesvalingstemperaturen, henstod derpå til afkøling til stuetemperatur, og omrørtes natten over. Opløsningen inddampedes delvist og hældtes ud i en is-vand-blanding. Chloroformlaget udvaskedes med fortyndet saltsyre, tørredes over natriumsulfat og inddampedes til en olieagtig remanens. Remanensen dækkedes med hexan, og der skrabedes i den, hvorved der dannedes et fast krystallinsk stof. Det krystallinske stof behandledes med kogende ethylacetat, og der tilsattes hexan, indtil blandingen blev uklar. Opløsningen henstod til afkøling, hvorved der blev opnået 50,6 g krystallinsk N-cyclopropylmethyl-2-(3-phenoxyphe-nyl)propionamid, smp. 94,5-96°C.The aqueous layer was saturated with sodium chloride and extracted again with chloroform. The chloroform extracts were combined and dried over sodium carbonate and sodium sulfate. The extracts were filtered and 50 ml of triethylamine were added. The mixture was cooled on an ice-acetone bath. To this was added dropwise the solution of acid chloride in chloroform. It was cooled and stirred throughout the addition. The reaction mixture was allowed to warm to room temperature, stirred for 30 minutes, heated to reflux temperature, then allowed to cool to room temperature, and stirred overnight. The solution was partially evaporated and poured into an ice-water mixture. The chloroform layer was washed with dilute hydrochloric acid, dried over sodium sulfate and evaporated to an oily residue. The residue was covered with hexane and scraped into it to give a solid crystalline substance. The crystalline substance was treated with boiling ethyl acetate and hexane was added until the mixture became cloudy. The solution was allowed to cool to give 50.6 g of crystalline N-cyclopropylmethyl-2- (3-phenoxyphenyl) propionamide, m.p. 94.5 to 96 ° C.

Analyse beregnet for C^gH^NC^: C 77,26; H 7,17; N 4,74;Analysis calculated for C C CH ^N NCC: C 77.26; H, 7.17; N, 4.74;

Fundet; C 77,14; H 7,17; N 4,71.found; C, 77.14; H, 7.17; N, 4.71.

EKSEMPEL 6-7EXAMPLES 6-7

De følgende forbindelser fremstilledes ifølge proceduren i eksempel 3 under anvendelse af de passende udgangsmaterialer; N-methyl-2-(3-phenoxyphenyl)butyramid., smp. 84-86°C.The following compounds were prepared according to the procedure of Example 3 using the appropriate starting materials; N-methyl-2- (3-phenoxyphenyl) butyramide., M.p. 84-86 ° C.

13 UU3913 UU39

Analyse beregnet for C^yH^gNOgt C 75,81; H 7,11; N 5,20;Analysis calculated for C ^ yHH gNOgt C 75.81; H, 7.11; N, 5.20;

Pundet: C 75,60; H 7,11; N 5,00.Pound: C, 75.60; H, 7.11; N, 5.00.

N-methyl-2-(3-phenoxyphenyl )propionamid, smp. 57-58°C.N-methyl-2- (3-phenoxyphenyl) propionamide, m.p. 57-58 ° C.

Analyse heregnet for C^gH^yNOg: C 75,27; H 6,71; N 5,49;Analysis for C ^ gHH yNOg: C, 75.27; H, 6.71; N, 5.49;

Fundet: C 75,51; H 6,86; N 5,61.Found: C, 75.51; H, 6.86; N, 5.61.

EKSEMPEL_8r10EKSEMPEL_8r10

De følgende forbindelser fremstilledes Ifølge proceduren i eksempel 4 ud fra det tilsvarende amid under anvendelse af de passende udgangsmaterialer: N-methyl-2-(3-phenoxyphenyl) butyl amin-hydrochlor id, smp. 124-126°C.The following compounds were prepared according to the procedure of Example 4 from the corresponding amide using the appropriate starting materials: N-methyl-2- (3-phenoxyphenyl) butyl amine hydrochloride, m.p. 124-126 ° C.

Analyse beregnet for C^yHg-^NO.HCl: C 69,96; H 7,60; N 4,80;Analysis calculated for C C CHH-NO.HCl: C, 69.96; H, 7.60; N, 4.80;

Fundet: C 69,83; H 7,80; N 4,87.Found: C, 69.83; H, 7.80; N, 4.87.

N-methyl-2-(3-phenoxyphenyl)propylamin-hydrochlorid, smp. 160-162°C.N-methyl-2- (3-phenoxyphenyl) propylamine hydrochloride, m.p. 160-162 ° C.

Analyse beregnet for C-^gH-^gNO.HC1: C 69,17; H 7,25; N 5,04;Analysis calculated for C- gHH ^NO.HCl: C 69.17; H, 7.25; N, 5.04;

Fundet: C 69,21; H 7,02; N 5,30.Found: C, 69.21; H, 7.02; N, 5.30.

N-cyclopropylmethyl-2-(3-phenoxyphenyl)propylamin-hydrochlorid, smp. 115-117°C.N-cyclopropylmethyl-2- (3-phenoxyphenyl) propylamine hydrochloride, m.p. 115-117 ° C.

Analyse beregnet for C^H^NO.HC1: C 71,79; H 7,61; N 4,40;Analysis calculated for C C HH NONO.HCl: C 71.79; H, 7.61; N, 4.40;

Fundet: C 71,96; H 7,46; N 4,39.Found: C, 71.96; H, 7.46; N, 4.39.

EKSEMPEL_11 A♦ 2-(3-bhenoxyphenyl)propylamln 100 g 2-(3-phenoxyphenyl)propionitril, fremstillet som i eksempel 2D, 10 g Raney-nikkel, 250 ml ethylalkohol og 150 g ammoniak kom bineredes i en trykbeholder under et hydrogen-begyndelsestryk på 14 141439 70 kp/em . Reaktionsblandingen blev holdt under tryk og opvarmet til 70-80°C under rystning i 4 timer, hvilket resulterede i en 91% hydrogenoptagelse. Efter afkøling og frafiltrering af katalysatoren blev reaktionsblandingen hældt ud i isvand, gjort sur med saltsyre, udvasket med ethylether, gjort basisk med 10% natriumhydroxidopløsning og ekstraheret med ethylether. Ethyletherlaget blev udvasket med vand, tørret over natriumsulfat og inddampet til en olieagtig remanens, der destilleredes, hvorved der blev opnået 78,9 g 2-(3-phenoxyphenyl)propylamin, k.p. 158-l6l°C/0,08 mmHg njp = 1,5752.EXAMPLE_11 A ♦ 2- (3-Bhenoxyphenyl) propylamine 100 g of 2- (3-phenoxyphenyl) propionitrile, prepared as in Example 2D, 10 g of Raney nickel, 250 ml of ethyl alcohol and 150 g of ammonia were combined in a pressure vessel under a hydrogen atom. initial pressure of 14 141439 70 kp / em. The reaction mixture was kept under pressure and heated to 70-80 ° C with shaking for 4 hours, resulting in a 91% hydrogen uptake. After cooling and filtering off the catalyst, the reaction mixture was poured into ice water, acidified with hydrochloric acid, washed with ethyl ether, basified with 10% sodium hydroxide solution and extracted with ethyl ether. The ethyl ether layer was washed with water, dried over sodium sulfate and evaporated to an oily residue, distilled to give 78.9 g of 2- (3-phenoxyphenyl) propylamine, b.p. 158-166 ° C / 0.08 mmHg njp = 1.5752.

Analyse beregnet for C-^H^NO: C 79,26; H 7,54; N 6,16Analysis calculated for C- HH ^ NONO: C 79.26; H, 7.54; N, 6.16

Pundet: C 79,18; H 7,29; N 6,07.Pound: C 79.18; H, 7.29; N, 6.07.

B. 2-(5-phenoxyphenyl)propylamin-hydrochlorid 20 g af det ovenfor fremstillede 2-(3-phenoxyphenyl)propylamin opløstes i ethylether, og den resulterende opløsning mættedes med hydrogenchloridgas, hvorved der dannedes et fast bundfald. Bundfaldet filtreredes fra, udvaskedes med ethylether, og opløstes i varm ethylalkohol. Der tilsattes ethylether indtil blandingen blev uklar, og reaktionsblandingen afkøledes, hvorpå man kradsede i den, hvorved der dannedes 18,9 g 2-(3-phenoxyphenyl)propylamin-hydrochlorid, smp. 147-147,5°C.B. 2- (5-Phenoxyphenyl) propylamine hydrochloride 20 g of the above 2- (3-phenoxyphenyl) propylamine were dissolved in ethyl ether and the resulting solution saturated with hydrogen chloride gas to give a solid precipitate. The precipitate was filtered off, washed with ethyl ether and dissolved in hot ethyl alcohol. Ethyl ether was added until the mixture became cloudy and the reaction mixture was cooled, then scraped into it to give 18.9 g of 2- (3-phenoxyphenyl) propylamine hydrochloride, m.p. 147 to 147.5 ° C.

Analyse beregnet for C^H-j^NO.HCl: C 68,30; H 6,88; N 5,31;Analysis calculated for C C CH-jNO.HCl: C, 68.30; H, 6.88; N, 5.31;

Fundet: C 68,11; H 6,58; N 5,32.Found: C, 68.11; H, 6.58; N, 5.32.

EKSEMPEL 12-21EXAMPLES 12-21

De følgende forbindelser blev også fremstillet ifølge proceduren i eksempel 4 under anvendelse af de passende udgangsmaterialer: N-cyclopropyl-2-(3-phenoxyphenyl)propylamin-hydrochlorid, smp., 129-131°C, pK'a 7,9.The following compounds were also prepared according to the procedure of Example 4 using the appropriate starting materials: N-cyclopropyl-2- (3-phenoxyphenyl) propylamine hydrochloride, mp, 129-131 ° C, pK'a 7.9.

Analyse beregnet for C^gE^NO.HCl: C 71,15; H 7,30; N 4,61Analysis calculated for C C CE ^NO.HCl: C, 71.15; H, 7.30; N, 4.61

Fundet: C 71,23; H 7,48; N 4,61.Found: C, 71.23; H, 7.48; N, 4.61.

N-methyl-2-(3-phenoxyphenyl)ethylamin-hydrochlorid, smp., 139-141°C, pK’a 9,7.N-methyl-2- (3-phenoxyphenyl) ethylamine hydrochloride, mp, 139-141 ° C, pK'a 9.7.

141439 15141439 15

Analyse beregnet for C^H^NO.HCl: C 68,30; H 6,88; N 5,31.Analysis calculated for C C CH NONO.HCl: C, 68.30; H, 6.88; N, 5.31.

Fundet: C 68,21; H 6,75; N 5,13.Found: C, 68.21; H, 6.75; N, 5.13.

N, N- dimethyl- 2- (3-phenoxyphenyl) ethylamin-hydrochlorid, smp,, 163-165°C, pK'a 8,5.N, N-dimethyl-2- (3-phenoxyphenyl) ethylamine hydrochloride, m.p., 163-165 ° C, pK'a 8.5.

Analyse beregnet for Cl6H19N0.HCl: C 69,18; H 7,26; N 5,04; 0 5,76.Analysis calculated for Cl 6 H 19 NO.HCl: C 69.18; H, 7.26; N, 5.04; 0. 5.76.

Fundet: C 69,38; H 7,45; N 5,07; 0 5,59.Found: C, 69.38; H, 7.45; N, 5.07; 0 5.59.

N- methyl-N-cyclopropyl-2- (3-phenoxyphenyl )propylamin-hydrochlorld, smp., 129-130°C, pk'a 6,9.N-methyl-N-cyclopropyl-2- (3-phenoxyphenyl) propylamine hydrochloride, m.p., 129-130 ° C, pk'a 6.9.

Analyse beregnet for C^I^NO.HCl: C 71,80; H 7,61; N 4,41.Analysis calculated for C ^ IH NO NOHCl: C 71.80; H, 7.61; N, 4.41.

Fundet: C 71,53; H 7,84; N 4,58.Found: C, 71.53; H, 7.84; N, 4.58.

N- methyl-N-cyclopropylmethyl-2- ( 3-phenoxyphenyl )propyl-amin-hydro-chlorid, smp., 90-92°C, pK*a 8,3.N-methyl-N-cyclopropylmethyl-2- (3-phenoxyphenyl) propylamine hydrochloride, m.p., 90-92 ° C, pK * a 8.3.

Analyse beregnet for C20H25N0,HC1: C 72,38; H 7,90; N 4,22; 0 4,82.Analysis calculated for C 20 H 25 NO, HCl: C 72.38; H, 7.90; N, 4.22; 0 4.82.

Fundet: C 72,33; H 7,90; N 4,41; 0 5,09.Found: C, 72.33; H, 7.90; N, 4.41; 0 5.09.

N-methyl-N- (2-phenyl ethyl )-2-( 3-phenoxyphenyl )pr opylamin-hydr ochlorld, smp. 137-138°C, pK'a 7,7.N-methyl-N- (2-phenylethyl) -2- (3-phenoxyphenyl) per opylamine hydr and chloride, m.p. 137-138 ° C, pK'a 7.7.

Analyse beregnet for Cg^HgyNO.HCl: C 75,46; H 7,39; N 3,67.Analysis calculated for C C CHgyNO.HCl: C 75.46; H, 7.39; N, 3.67.

Fundet: C 75,23; H 7,58; N 3,56.Found: C, 75.23; H, 7.58; N, 3.56.

N- ally 1-2-(3-phenoxyphenyl)propylamin-hydrochlorid, smp. 118-120°C, pK’a 8,5·N-ally 1-2- (3-phenoxyphenyl) propylamine hydrochloride, m.p. 118-120 ° C, pK'a 8.5 ·

Analyse beregnet for C^gNg^NO: C 71,16; H 7,30; N 4,61.Analysis calculated for C ^ gNg ^NO: C, 71.16; H, 7.30; N, 4.61.

Fundet: C 71,13; H 7,50; N 4,54.Found: C, 71.13; H, 7.50; N, 4.54.

N- (2- phenylethyl) -2- (3-phenoxyphenyl )pr opylamin-hydrochlorid, smp., 120-124°C.N- (2-phenylethyl) -2- (3-phenoxyphenyl) per opylamine hydrochloride, m.p., 120-124 ° C.

Analyse beregnet for C2^H2^N0.HC1: C 75,08; H 7,12; N 3,81.Analysis calculated for C₂ ^H₂ ^NO.HCl: C 75.08; H, 7.12; N, 3.81.

Fundet: C 75,11; H 7,30; N 3,64.Found: C, 75.11; H, 7.30; N, 3.64.

16 141439 N-methyl-3- (3-phenoxyphenyl)butylamin-hydrochlorid, smp. 124-126°C, pK’a 10,0.N-methyl-3- (3-phenoxyphenyl) butylamine hydrochloride, m.p. 124-126 ° C, pK'a 10.0.

Analyse beregnet for HC1: C 69,96; H 7,60; N 4,80.Analysis calculated for HCl: C, 69.96; H, 7.60; N, 4.80.

Fundet: 069,83; H 7,80; N 4,87.Found: 069.83; H, 7.80; N, 4.87.

3-(3-phenoxyphenyl )butylamin-hydrochlorid, smp. 133-135°C, pK'a 10,0.3- (3-phenoxyphenyl) butylamine hydrochloride, m.p. 133-135 ° C, pK'a 10.0.

Analyse beregnet for C^gH^NO.HCl: C 69,17; H 7,26; N 5,04.Analysis calculated for C C CH ^ NONO.HCl: C, 69.17; H, 7.26; N, 5.04.

Fundet: C 69,36; H 7,47; N 5,06.Found: C, 69.36; H, 7.47; N, 5.06.

EKSEMPEL 22 N-methyl-N-(3-methylbut-2-enyl)-2-(3-phenoxyphenyl)propylamin-hydrochlorid_____EXAMPLE 22 N-methyl-N- (3-methylbut-2-enyl) -2- (3-phenoxyphenyl) propylamine hydrochloride

En blanding af 23,9 g N-methyl-2-(3-phenoxyphenyl )propylamin og 13,8 g kaliumcarbonat i benzen blev behandlet med 20,8 g 1-chlor- 3-methyl-2-buten. Reaktionsblandingen blev opvarmet under tilbagesvaling med mekanisk omrøring i 60 timer. Efter afkøling til stuetemperatur blev reaktionsblandingen vasket med vand og ekstraheret med fortyndet saltsyre. Den sure ekstrakt blev gjort basisk med natriumhydroxidopløsning og ekstraheret med ether. Etherekstrakten blev vasket to gange med vand og tørret over natriumsulfat. Tør hydrogenchloridgas blev derpå ledt ind i etheropløsningen, og det udfældede hydrochloridsalt blev frafiltreret og omkrystalliseret fra en alkohol/ether-blanding, hvorved der blev opnået 11,5 g af det ovennævnte produkt, smp. 120-122° C, pK*a 8,5·A mixture of 23.9 g of N-methyl-2- (3-phenoxyphenyl) propylamine and 13.8 g of potassium carbonate in benzene was treated with 20.8 g of 1-chloro-3-methyl-2-butene. The reaction mixture was heated under reflux with mechanical stirring for 60 hours. After cooling to room temperature, the reaction mixture was washed with water and extracted with dilute hydrochloric acid. The acidic extract was made basic with sodium hydroxide solution and extracted with ether. The ether extract was washed twice with water and dried over sodium sulfate. Dry hydrogen chloride gas was then introduced into the ether solution and the precipitated hydrochloride salt was filtered off and recrystallized from an alcohol / ether mixture to give 11.5 g of the above product, m.p. 120-122 ° C, pK * a 8.5 ·

Analyse beregnet for Cg-jH NQ.HC1: C 72,92; H 8,16; N 4,05.Analysis calculated for Cg -H NNQ.HCl: C 72.92; H 8.16; N, 4.05.

Fundet: C 72,87; H 8,34; N 4,04.Found: C, 72.87; H, 8.34; N, 4.04.

EKSEMPEL 25 N-methyl-N-allyl-2-(3-phenoxyphenyl)propylamin-hydrochlorid, smp. 135-136° C, pK’a 7,6, blev fremstillet ved proceduren i eksempel 4.EXAMPLE 25 N-Methyl-N-allyl-2- (3-phenoxyphenyl) propylamine hydrochloride, m.p. 135-136 ° C, pK'a 7.6, was prepared by the procedure of Example 4.

Analyse beregnet for C^H^NO.HCl: C 71,79; H 7,61; N 4,41.Analysis calculated for C C CH NONO.HCl: C 71.79; H, 7.61; N, 4.41.

Fundet: C 71,63; H 7,80; N 4,21.Found: C, 71.63; H, 7.80; N, 4.21.

17 UU 3917 UU 39

En række af de omhandlede forbindelser er blevet testet for anti-inflammatorisk virkning i en erythema-blokerlngstest på følgende måde:A number of the compounds of this invention have been tested for anti-inflammatory action in an erythema-blocking test as follows:

Der benyttes en metode, som er en modifikation af den af C.V. Vinder et al. beskrevne metode (C.V. Vinder, V. Burr og C.E. Posierej "A Study of Pharmacological Influences on Ultraviolet Erythrea in Guinea Pigs", Arch. Int. Fharmacodyn., 116, 261, 1958). Ved denne metode anvendes marsvin (albinoer) af begge køn med en vægt på 225-30Q g. Marsvinene barberes på ryggen og depilleres kemisk (NAIR , Lotion Hair Remover, Carter Products, N.Y., N.Y.). Efter 18 til 20 timers forløb udsættes dyrene for ultraviolet bestråling efter at have fastet natten over. Umiddelbart efter behandlingen med en af de omhandlede forbindelser anbringes et beskyttende stykke selvklæbende papir på ryggen af dyrene, hvorefter de udsættes for ultraviolet bestråling med høj intensitet i 7 sekunder. Den ultraviolette lyskilde anbringes i kontakt med huden på ryggen af dyrene. Derefter fjernes det beskyttende papir, og marsvinenes rygge renses med en gazetampon dyppet i vand. Det stykke af huden, som har været beskyttet af papiret, virker som et kontrastområde ved bedømmelsen af den dannede erythema. Dyrene anbringes i holdere af gennemsigtig plastik. Efter 60, 90, 120 og 150 minutters forløb, bedømmes graden af den resulterende erythema efter et arbitrært pointsystem, som er baseret på graden af kontrast og dannet rødme.A method is used which is a modification of that of C.V. Winner et al. described method (C.V. Winner, V. Burr and C.E. Posierej "A Study of Pharmacological Influences on Ultraviolet Erythrea in Guinea Pigs", Arch. Int. Fharmacodyn., 116, 261, 1958). This method uses guinea pigs (albinos) of both sexes weighing 225-30Q g. The guinea pigs are shaved on their backs and chemically distilled (NAIR, Lotion Hair Remover, Carter Products, N.Y., N.Y.). After 18 to 20 hours, the animals are exposed to ultraviolet radiation after fasting overnight. Immediately after treatment with one of the compounds in question, a protective piece of self-adhesive paper is placed on the backs of the animals, after which they are exposed to high intensity ultraviolet radiation for 7 seconds. The ultraviolet light source is placed in contact with the skin on the back of the animals. The protective paper is then removed and the guinea pigs' backs are cleaned with a gauze tampon dipped in water. The piece of skin that has been protected by the paper acts as a contrasting area when assessing the erythema formed. The animals are placed in transparent plastic holders. After 60, 90, 120, and 150 minutes, the degree of the resulting erythema is judged by an arbitrary scoring system based on the degree of contrast and redness formed.

Anti-inflammatoriske midler forsinker udviklingen af erythema og har derfor størst virkning ved de første bedømmelser. Derfor af-vejes bedømmelserne med en faktor 4, 3, 2 og 1 ved bedømmelse efter henholdsvis 60, 90, 120 og 150 minutter. Den dannede erythema bedømmes på følgende måde:Anti-inflammatory agents delay the development of erythema and therefore have the greatest effect in the initial assessments. Therefore, the judgments are weighed by a factor of 4, 3, 2 and 1 when judged after 60, 90, 120 and 150 minutes respectively. The erythema formed is evaluated as follows:

Bedømmelsessystem for erythema Udseende af behandlet områdeErythema Assessment System Appearance of treated area

Bedømmelse 0 Ingen rødmen og ingen kontrast 1 Let rødmen med svagt omrids af beskyttelsespapiret 2 Let til moderat rødmen med tydeligt omrids 3 Udpræget rødmen med tydeligt cirkulært omridsRating 0 No blush and no contrast 1 Light blush with slight outline of the protective paper 2 Light to moderate blush with clear outline 3 Distinct blush with clear circular outline

Den totale bedømmelse fra hver gruppe af behandlede dyr (5 eller 6 marsvin i hver gruppe) sammenlignes med en kontrolgruppe, og den procentvise inhibering beregnes efter følgende formel: 18 1.41438The total assessment from each group of treated animals (5 or 6 guinea pigs in each group) is compared to a control group and the percentage inhibition is calculated by the following formula: 18 1.41438

Kontrol - Behandlet 100 x kontrol = procent inhiberingControl - Treated 100 x control = percent inhibition

Testforbindelseme fremstilles i en suspension af 1% methylcellu-lose i vand og indgives oralt. Marsvinene behandles oralt med 1 ml suspension pr. kg legemsvægt. Kontroldyrene behandles med 1 ml pr. kg legemsvægt af en 1% suspension af methylcellulose. Den dosering i mg pr. kg, som bevirker en 50 % inhibering af det erythe-miske respons (ED^q) er anført i den efterfølgende tabel I for en række af de omhandlede forbindelser: _ Tabel I:The test compounds are prepared in a suspension of 1% methylcellulose in water and administered orally. Guinea pigs are treated orally with 1 ml suspension per day. kg body weight. Control animals are treated with 1 ml per day. kg body weight of a 1% suspension of methyl cellulose. The dosage in mg per kg, which causes a 50% inhibition of the erythematous response (ED ^ q) is listed in the following Table I for a number of the compounds concerned: Table I:

CHCH

q/ Erythema-blokeringstest \=J Oral ED^q _ R_ (mg forbindelse/kg legemsvægt) CH2CH2NH2*HC1 75 CH2CH2NHCH3-HC1 lo CH2CH2N(CH3)2*HC1 7 (j3H-CH2NH2*HCl 1 0¾ 3 CH-CH2NHCH3-HC1 1 CH^ pH-CH2N(.CH3)2-HCl 8 CH, CH-CH9NH-CH<f I * .HC1 9 k CH2 3 /9H2 (j;h-ch2nhch2chQ | -hci 20 CH, CH2 3 /CH, GH-CH9-N< . ^^CH^-HCl 3 L ^CH<f ] 2q / Erythema Blocking Test \ = J Oral ED ^ q _ R_ (mg compound / kg body weight) CH2CH2NH2 * HC1 75 CH2CH2NHCH3-HC1 lo CH2CH2N (CH3) 2 * HC1 7 (j3H-CH2NH2 * HCl 1 0 3 CH-CH2NHCH3 HCl 1 CH2 pH-CH2N (.CH3) 2-HCl8CH, CH-CH9NH-CH <f I * .HC1 9 k CH2 3 / 9H2 (j; h-ch2nhch2chQ | -hci 20 CH, CH2 3 / CH , GH-CH9-N <. ^^ CH ^ -HCl 3 L ^ CH <f] 2

Ch5 \6h2 CH-CH~N< ^ ΛΗ0 3 L· * ^0¾ - CH< \ 2 *HC1 CH3 2 \CH2 CH-CH2imCH2CH=CH2 · HC1 10 CH, 3 14U39 19CH5 \ 6h2 CH-CH ~ N <^ ΛΗ0 3 L · * ^ 0¾ - CH <\ 2 * HC1 CH3 2 \ CH2 CH-CH2imCH2CH = CH2 · HC1 10 CH, 3 14U39 19

Erythema-blokeringstestErythema blocking test

_R_ Oral ED^Q_R_ Oral ED ^ Q

qjj (mg/forbindelse/kg legemsvægt) CHCH-N^ 3 /CH, 15qjj (mg / compound / kg body weight) CHCH-N ^ 3 / CH, 15

Ja ^CH0CH=C<" 5.HC1 CH3 2 ^ CH3Yes ^ CHOCH = C <"5.HC1 CH3 2 ^ CH3

CfiC^NHCHgC^Ø-HCl 5 CH, 5 . CH, CHCH9NCT d -HC1 2 crH ^ ^ch2ch2øCfiC ^ NHCHgC ^ E-HCl 5 CH, 5. CH, CHCH9NCT d -HC1 2 crH ^^ ch2ch2ø

CjH-CH2CH2CH2NHCH3 * HC1 5 η Sammgnll'gnlngsf orMndélser: ch-ch2oc-nhch3 L 40 5 / CH- C-NHq I 3 ch3 0 CH-C-NHCH, T 3 30 CH, 3 O CH, // „ ^ 3 CH-C-H^ I \ 25 l CH, CH3 3 Ϊ (jH-C-NHOH 2 ch3 CH-C-NHCH2C00H 5 ch3 acetylsalicylsyre 50 141439 20CjH-CH₂CH2CH2NHCH3 * HCl 5 η Comparative Compounds: ch-ch2oc-nhch3 L 40 5 / CH-C-NHq I 3 ch3 O CH-C-NHCH, T 3 CH, 3 O CH, // 3 CH-CH2 I \ 25 l CH, CH3 3 Ϊ (jH-C-NHOH 2 ch3 CH-C-NHCH2C00H 5 ch3 acetylsalicylic acid 50

Inhiberingen af eddikesyre-inducerede vridninger hos mus benyttes til at demonstrere den relative analgetiske virkning af de omhandlede forbindelser. Til eftervisning af den analgetiske virkning af forbindelserne benyttes en metode, der svarer til metoden beskrevet af R. Koster et al., "Acetic Acid for Analgesic Screening" Fed. Proc,, 18;412 (1959). Man går frem på følgende måde:The inhibition of acetic acid-induced twisting in mice is used to demonstrate the relative analgesic effect of the compounds of the invention. To demonstrate the analgesic effect of the compounds, a method similar to that described by R. Koster et al., "Acetic Acid for Analgesic Screening" Fed. Proc., 18; 412 (1959). Here's how:

Der benyttes albino-hanmus, som vejer 16 - 18g. Musene modtager behandling ad subcutan vej eller gennem maven. På forskellige tidspunkter efter behandlingen induceres vridninger ved intraperitonea-le indgivelse af 0,6% eddikesyre. Hver gruppe består af 6 mus.Male albino mice weighing 16 - 18g are used. The mice receive treatment by subcutaneous route or through the abdomen. At various times after treatment, twisting is induced by intraperitoneal administration of 0.6% acetic acid. Each group consists of 6 mice.

Det totale antal vridninger i en gruppe på 6 mus bestemmes i en periode på 5 - 15 minutter efter behandlingen med eddikesyre.The total number of twists in a group of 6 mice is determined over a period of 5 - 15 minutes after the acetic acid treatment.

Den procentvise hæmning ved behandlingen med de omhandlede forbindelser bestemmes ved sammenligning med ubehandlede kontrolmus efter følgende formel:The percent inhibition in treatment with the compounds of the invention is determined by comparison with untreated control mice according to the following formula:

f Totalt antal vridninger (behandl.)x 100 Jf Total number of turns (processing) x 100 J

Procent inhibering = 100 - —---- . . ......... IPercent Inhibition = 100 - —----. . ......... I

\Totalt antal vridninger (kontrol) /\ Total number of turns (control) /

De i tabel II anførte ED^Q-værdier angiver de doseringer i milligram pr. kilo legemsvægt, som fremkalder en 50% inhibering af frekvensen af vridningerne.The ED ^ values listed in Table II indicate the dosages in milligrams per milligram. pounds of body weight which induces a 50% inhibition of the frequency of the twists.

21 141439 TABEL II:TABLE II:

Testforbindelse Analgetisk vridningstest 2- (3-phenoxyph.enyl) -R Subkutant ED^q hvor R er_ mg/kg___ CH2CH2NH2.HC1 4· CH2CH2NHCH3.HC1 25 ch3 ch2ch2nT · HC1 3-5 t^H3 CHCH25H2·SCI 20 f ch3 CH-CH2NHCH3*HC1 20 ch3 CH-CH2K(CH3)2-HC1 , 10Test compound Analgesic torsion test 2- (3-phenoxyphenyl) -R Subcutaneous ED ^ q where R is_mg / kg ___ CH2CH2NH2. -CH2NHCH3 * HC1 ch3 CH-CH2K (CH3) 2-HCl, 10

Jh3 CH-CH2NHCH3*HC1 20 ch2ch3 CHa CH-CH2-Ii-CH2-CH^| · HC1 < $0 ot K ^Jh3 CH-CH2NHCH3 * HCl CH2CH3 CHa CH-CH2-II-CH2-CH ^ | · HC1 <$ 0 ot K ^

Acetylsalicylsyre 20Acetylsalicylic acid 20

Claims (2)

22 141439 Patentkrav : Analogifremgangsmåde til fremstilling af 3-phenoxyphenylalkylamin-forbindelser med den almene formel r1 rz (/ \-CH-(CH9) -CH9-N ^ \3 ΓΧ-*' hvori n er 0, 1 eller 2, R"*· betyder hydrogen eller alkyl med 1-5Patent Claims: Analogous Process for the Preparation of 3-Phenoxyphenylalkylamine Compounds of the General Formula R1 - ((\ -CH- (CH9) -CH9-N ^ \ 3 ΓΧ- * 'wherein n is 0, 1 or 2, R " * · Means hydrogen or alkyl of 1-5 2 K carbonatomer, og R og R, der er ens eller forskellige, betyder hydrogen, alkyl med 1-5 carbonatomer, alkenyl med 2-6 carbonatomer, cyclopropyl, cyclopropylmethyl eller phenethyl, eller farmaceutisk acceptable syreaddit ions salte deraf, kendetegnet ved, at a) et amid med formlen >-^ R1 o R2 jT\ i li / V 7-CH-(CH2)n-C-N^ 12 3 hvori n, R , R og R har den ovennævnte betydning, reduceres kemisk, eller b) en nitril med formlen2 K carbon atoms and R and R being the same or different means hydrogen, alkyl of 1 to 5 carbon atoms, alkenyl of 2-6 carbon atoms, cyclopropyl, cyclopropylmethyl or phenethyl, or pharmaceutically acceptable acid addition salts thereof, characterized in that a) an amide of the formula> - ^ R1 o R2 jT \ i li / V 7-CH- (CH2) nCN ^ 12 3 wherein n, R, R and R have the above meaning are chemically reduced, or b) a nitrile with the formula
DK240577A 1968-08-15 1977-06-01 Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof. DK141439B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK240577A DK141439B (en) 1968-08-15 1977-06-01 Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof.

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US75280168A 1968-08-15 1968-08-15
US75280068 1968-08-15
US75280168 1968-08-15
US752800A US3649679A (en) 1968-08-15 1968-08-15 Substituted phenylalkanoic acid derivatives ii
US828756A US3600437A (en) 1969-05-28 1969-05-28 Substituted phenylalkanoic acids and derivatives thereof
US82875669 1969-05-28
DK436169A DK145778C (en) 1968-08-15 1969-08-14 ANALOGY PROCEDURE FOR PREPARING 3-PHENOXYPHENYLALKANIC ACID DERIVATIVES
DK436169 1969-08-14
DK240577 1977-06-01
DK240577A DK141439B (en) 1968-08-15 1977-06-01 Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof.

Publications (3)

Publication Number Publication Date
DK240577A DK240577A (en) 1977-06-01
DK141439B true DK141439B (en) 1980-03-17
DK141439C DK141439C (en) 1980-09-15

Family

ID=27512902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK240577A DK141439B (en) 1968-08-15 1977-06-01 Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof.

Country Status (1)

Country Link
DK (1) DK141439B (en)

Also Published As

Publication number Publication date
DK240577A (en) 1977-06-01
DK141439C (en) 1980-09-15

Similar Documents

Publication Publication Date Title
JPS63264557A (en) Indane-, dihydrobenzofuran-, dihydrobenzothiophene- and indoline-derivatives, acid addition salts, isomers and manufacture
FR2562539A1 (en) NOVEL DERIVATIVES OF VINYL-4 BENZOIC ACID, PROCESS FOR PREPARING THEM AND THEIR THERAPEUTIC AND LIGAND APPLICATIONS
JPH0419221B2 (en)
JP2870925B2 (en) Ethers of aliphatic 2-hydroxy acids and 1-benzyl-3-hydroxymethyl-indazole
DK145778B (en) ANALOGY PROCEDURE FOR PREPARING 3-PHENOXYPHENYLALKANIC ACID DERIVATIVES
US4605672A (en) Diethylaminoalkoxybenzhydrol derivatives, process for their preparation and pharmaceutical compositions containing them
DK169538B1 (en) Amino alcohols and acid addition salts thereof, processes for their preparation and drugs containing such
US3989746A (en) Substituted naphthyl anthranilic acids
DK141439B (en) Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof.
US3890377A (en) 3-Substituted phenylalkanohydroxamic acids
JPS58979A (en) Manufacture of medicinal composition containing imidazo(1,4-a)pyridine substituent and use as remedy
US4201725A (en) Secondary amines
DE68909757T2 (en) Indane derivatives, processes for their preparation and intermediates obtained, their use as medicaments and pharmaceutical compositions containing them.
US3972934A (en) 3-Substituted phenylalkyl amines
US4001322A (en) 3-substituted phenylalkyl amines
US3853905A (en) Certain 5-(phenoxyphenalkyl) tetrazoles
JPS61282348A (en) Amine compound and antifungal agent containing said amine compound as active constituent
FR2465733A1 (en) NOVEL IMIDAZOLYLETHOXYMETHYLIC DERIVATIVES OF 1,3-DIOXOLOQUINOLINES USEFUL AS ANTIBACTERIAL AND ANTIFUNGAL DRUGS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS AND PHARMACEUTICAL FORMS CONTAINING THEM
US3296276A (en) Novel 1-oxo-3-phenyl isoindolines
US4057644A (en) Active derivatives of methylamine in therapeutic compositions and methods of use
EP0135406A1 (en) Pyrrolidinones potent on the central nervous system, process for their preparation and medicines containing them
US4062895A (en) 2-(3-Phenoxyphenyl) propanol
GB1565021A (en) Pharmaceutical compositions containing alkylamine deratives
NO750175L (en)
US4145557A (en) (Phenoxyphenyl) alkyl acetates, propionates, and carbamates

Legal Events

Date Code Title Description
PUP Patent expired